Using Neuroimaging to Inform Drug Development Throughout the Pathologic Trajectory

Time: 10:00 am - 10:20 am
day: Day One


  • Highlight medical imaging techniques for CNS drug development
  • Examine why imaging biomarkers provide insight into drug mechanism by informing target engagement and pharmacologic activation
  • Explore how these markers will also be crucial for prevention trials, where interventions may occur decades in advance of any clinical symptom
  • Understand how these advanced imaging techniques can be deployed in the clinical trial space